Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Imago BioSciences's (NASDAQ:IMGO) short percent of float has risen 41.79% since its last report. The company recently repor...
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Imago BioSciences, Inc. ("Imago" or the "Company") (NASDAQ:IMGO), a clinical-stage biopharmaceutical company di...
Imago BioSciences, Inc. (“Imago”) (NASDAQ:IMGO), a clinical-stage biopharmaceutical company discovering and developing new medi...
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tende...
Imago BioSciences's (NASDAQ:IMGO) short percent of float has fallen 3.48% since its last report. The company recently repor...
Imago BioSciences, Inc. ("Imago") (NASDAQ:IMGO), a clinical-stage biopharmaceutical company discovering and developing...
